Neurofibromatosis type 1 causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 4: Line 4:
{{CMG}}; {{AE}}[[User:MoisesRomo|Moises Romo M.D.]]  
{{CMG}}; {{AE}}[[User:MoisesRomo|Moises Romo M.D.]]  
==Overview==
==Overview==
To review risk factors for the development of [disease name], click [[Neurofibromatosis type 1 risk factors|here]].
 
'''[[Neurofibromatosis type 1]]''' can be caused 50% of the time due to an [[autosomal dominant]] [[Inherited|inherited pattern]] with the other 50% beign caused due to a [[De novo mutation|''de novo'' mutation]] on [[NF1]] [[gene]].
To review [[Risk factor|risk factors]] for the development of [[neurofibromatosis type 1]], click [[Neurofibromatosis type 1 risk factors|here]].


==Causes==
==Causes==
Neurofibromatosis type 1 is a relatively common inherited disorder. The development of this disease is always due to a mutation in the NF1 gene from chromosome 17, which in turn, produces a defective neurofribromin protein.


50% of cases of neurofibromatosis type 1 are inherited, with the remainder beign ''de novo'' NF1 mutation.<ref name="pmid28230061" /><ref name="pmid18956796">{{cite journal |vauthors=McKeever K, Shepherd CW, Crawford H, Morrison PJ |title=An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age |journal=Ulster Med J |volume=77 |issue=3 |pages=160–3 |date=September 2008 |pmid=18956796 |pmc=2604471 |doi= |url=}}</ref>
* [[Neurofibromatosis type 1]] is a relatively common [[inherited]] disorder. The development of this disease is always due to a [[mutation]] in the [[NF1|NF1 gene]] from [[chromosome 17]], which in turn, produces a defective [[neurofibromin]] [[protein]].
* 50% of cases of [[neurofibromatosis type 1]] are [[inherited]], with the remainder beign ''[[de novo]]'' [[NF1]] [[mutation]].<ref name="pmid28230061" /><ref name="pmid18956796">{{cite journal |vauthors=McKeever K, Shepherd CW, Crawford H, Morrison PJ |title=An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age |journal=Ulster Med J |volume=77 |issue=3 |pages=160–3 |date=September 2008 |pmid=18956796 |pmc=2604471 |doi= |url=}}</ref>


=== ''De novo'' mutation ===
=== ''De novo'' mutation ===
Neurofibromatosis type 1 due to ''de novo'' mutations of NF1, occur in the absence of a family history of the disease, usually from a paternal germline cell mutation.<ref name="pmid9358268">{{cite journal |vauthors=Bunin GR, Needle M, Riccardi VM |title=Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues |journal=Genet. Epidemiol. |volume=14 |issue=5 |pages=507–16 |date=1997 |pmid=9358268 |doi=10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y |url=}}</ref><ref name="pmid28230061" />
Causes for NF1 gene mutation are the following:
Small deletions 22.4%
Large insertions 1.2%
Small insertions 11%
Non-sense mutations 17.5%
Missense mutations 11.8%
intronic mutations affecting RNA splicing 10.2%
3-UTR region mutations 1.6%<ref name="urlwww.orpha.net">{{cite web |url=https://www.orpha.net/data/patho/Pro/en/Neurofibromatosis1-FRenPro185.pdf |title=www.orpha.net |format= |work= |accessdate=}}</ref>


* [[Neurofibromatosis type 1]] due to ''[[de novo]]'' mutations of [[NF1]], occur in the absence of a family history of the disease, usually from a paternal [[Germline mutation|germline cell mutation]].<ref name="pmid9358268">{{cite journal |vauthors=Bunin GR, Needle M, Riccardi VM |title=Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues |journal=Genet. Epidemiol. |volume=14 |issue=5 |pages=507–16 |date=1997 |pmid=9358268 |doi=10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y |url=}}</ref><ref name="pmid28230061" />
*Multiple ''[[de novo]]'' [[pathogenic]] varients is possible in a same family of individuals with [[neurofibromatosis type 1]].<ref name="pmid203012883" /><ref name="pmid12483293">{{cite journal |vauthors=Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN |title=Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1 |journal=Hum. Genet. |volume=112 |issue=1 |pages=12–7 |date=January 2003 |pmid=12483293 |doi=10.1007/s00439-002-0840-1 |url=}}</ref>
* Causes for [[NF1|NF1 gene]] [[mutation]] are the following:


{| class="wikitable"
{| class="wikitable"
|+
|+
!Causes for NF1 gene mutation
!Causes for NF1 gene mutation
!Percentage  
!Percentage
|-
|-
|Small deletions
|Small deletions
|22.4%<ref name="urlwww.orpha.net" />
|22.4%<ref name="urlwww.orpha.net">{{cite web |url=https://www.orpha.net/data/patho/Pro/en/Neurofibromatosis1-FRenPro185.pdf |title=www.orpha.net |format= |work= |accessdate=}}</ref>
|-
|-
|Non-sense mutations  
|Non-sense mutations
|17.5%<ref name="urlwww.orpha.net" />
|17.5%<ref name="urlwww.orpha.net" />
|-
|-
Line 67: Line 55:
|}
|}


 
* Advanced [[Paternal age effect|paternal age]] increases probability of an [[NF1]] ''[[de novo]]'' [[mutation]].<ref name="pmid28230061" />
* The mutation rate for the ''[[NF1]]'' [[gene]], 4.37 (± 0.72) per 100,0000.<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics">{{cite web |url=https://jmg.bmj.com/content/37/8/632 |title=Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland &#124; Journal of Medical Genetics |format= |work= |accessdate=}}</ref><br />
=== Inherited (familial) ===
=== Inherited (familial) ===


 
* [[Heterozygous]] pathogenic variants in ''[[NF1]] [[gene]]'' are responsible for the developement of [[neurofibromatosis 1]] disease.<ref name="pmid20301288" />
CausesOne of the potential etiologies for non-familial Neurofibromatosis Type 1 (NF1) is increasing parental age. We sought to evaluate recent evidence for parental age effects in NF1 in a large study. Individuals with NF1 and a comparison group from the U.S. general population born between 1994 and 2012 were ascertained from the NF1 Patient Registry Initiative (NPRI) and the National Center for Vital Statistics, respectively.<ref name="pmid28230061">{{cite journal |vauthors=Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ |title=Neurofibromatosis type 1 |journal=Nat Rev Dis Primers |volume=3 |issue= |pages=17004 |date=February 2017 |pmid=28230061 |doi=10.1038/nrdp.2017.4 |url=}}</ref>
* [[Neurofibromatosis type 1]] is inherited in an autosomal dominant fashion.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH" /><ref name="pmid282300612">{{cite journal |vauthors=Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ |title=Neurofibromatosis type 1 |journal=Nat Rev Dis Primers |volume=3 |issue= |pages=17004 |date=February 2017 |pmid=28230061 |doi=10.1038/nrdp.2017.4 |url=}}</ref>
 
*Inherited [[neurofibromatosis type 1]] has 100% [[penetrance]] (no skipping generations).<ref name="pmid203012883" /><ref name="pmid2511318">{{cite journal |vauthors=Huson SM, Compston DA, Clark P, Harper PS |title=A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity |journal=J. Med. Genet. |volume=26 |issue=11 |pages=704–11 |date=November 1989 |pmid=2511318 |pmc=1015740 |doi=10.1136/jmg.26.11.704 |url=}}</ref>
 
* Unlike many [[Autosomal dominant inheritance|autosomal dominant]] disorders, where one defective copy of a [[gene]] can produce the [[phenotype]], in [[neurofibromatosis type 1]], [[mutation]] of two copies are necessary to develope the presentation, this means that many people who inherit only one copy [[mutation]] need for a second mutation during lifetime for [[neurofibroma]]<nowiki/>s and other characteristics to arise.<ref name="urlNeurofibromatosis type 1 - Genetics Home Reference - NIH">{{cite web |url=https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-1#inheritance |title=Neurofibromatosis type 1 - Genetics Home Reference - NIH |format= |work= |accessdate=}}</ref>
Our linkage studies showed that linked markers/haplotypes show the same result as careful clinical examination in familial cases of NF1, although contradictory results were obtained in two families where linkage data showed the NF1 risk haplotype in a healthy child of an affected parent. One explanation may be that the children were affected but were still at a presymptomatic stage. This would be exceptional, as all our affected cases (reported separately) had developed café au lait macules by the age of 5 years (96% of all patients), and similar observations have been made in earlier reports.<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics">{{cite web |url=https://jmg.bmj.com/content/37/8/632 |title=Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland &#124; Journal of Medical Genetics |format= |work= |accessdate=}}</ref><ref name="pmid3145091">{{cite journal |vauthors=Huson SM, Harper PS, Compston DA |title=Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales |journal=Brain |volume=111 ( Pt 6) |issue= |pages=1355–81 |date=December 1988 |pmid=3145091 |doi=10.1093/brain/111.6.1355 |url=}}</ref> Another explanation would be that even though the affected parents in both families fulfilled the NIH diagnostic criteria for NF1 (in the first family CFS and freckles, and in the second family neurofibromas and Lisch nodules), they both have another type of NF which is not linked to the ''NF1'' gene. A third explanation would be mosaicism in a parent with NF1 in whom some of the germ cells do not carry the ''NF1'' mutation. A fourth explanation would be non-penetrance of the''NF1'' mutation in the children in question, which has previously been reported in only three cases, a 50 year old woman who had an affected brother, son, and grandson,<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics" /><ref name="pmid8825042">{{cite journal |vauthors=Shen MH, Harper PS, Upadhyaya M |title=Molecular genetics of neurofibromatosis type 1 (NF1) |journal=J. Med. Genet. |volume=33 |issue=1 |pages=2–17 |date=January 1996 |pmid=8825042 |pmc=1051805 |doi=10.1136/jmg.33.1.2 |url=}}</ref> a 45 year old man with an affected mother and daughter,<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics" /><ref name="pmid8825042" /> and a subject with an affected father and two affected daughters.<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics" /><ref name="pmid3105393">{{cite journal |vauthors=Spence MA, Parry DM, Bader JL, Marazita ML, Bocian M, Funderburk SJ, Mulvihill JJ, Sparkes RS |title=Genetic linkage analysis of neurofibromatosis |journal=Ann. N. Y. Acad. Sci. |volume=486 |issue= |pages=287–92 |date=1986 |pmid=3105393 |doi=10.1111/j.1749-6632.1986.tb48081.x |url=}}</ref> Although non-paternity is not probable, one should exclude it with other markers. The finding of possible non-penetrance in the two families in this series will be finally answered only after the families' ''NF1''mutation has been found.
* Due to [[neurofibromatosis type 1]] high prevalence, other concomittant [[autosomal dominant]] disorders have been reported, such as [[Noonan syndrome]], [[multiple endocrine neoplasia type 2]], and [[Huntington disease]].<ref name="pmid19449407">{{cite journal |vauthors=Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A |title=Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome |journal=Am. J. Med. Genet. A |volume=149A |issue=6 |pages=1263–7 |date=June 2009 |pmid=19449407 |doi=10.1002/ajmg.a.32837 |url=}}</ref>
 
*[[Neurofibromatosis type 1]] [[mosaicism]] may also appear and be limited to one segment of the body.<ref name="pmid20301288" />
The mutation rate for the ''NF1'' gene, 4.37 ± 0.72 × 10-5,.<ref name="urlEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics" />
*Parents with [[Mosaic (genetics)|mosaicism]] of [[neurofibromatosis type 1]] have less 50% of chance to [[Transmittance|transmit]] the condition to its child, but if transmitted, the [[mutation]] will be present in every [[Cell (biology)|cell]] of the [[newborn]], presenting a severe variant.<ref name="pmid203012883">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, Friedman JM |title= |journal= |volume= |issue= |pages= |date= |pmid=20301288 |doi= |url=}}</ref><br />




Causes of NF1


<br />
<br />

Latest revision as of 14:11, 1 September 2020

Neurofibromatosis type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibromatosis type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibromatosis type 1 causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibromatosis type 1 causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibromatosis type 1 causes

CDC on Neurofibromatosis type 1 causes

Neurofibromatosis type 1 causes in the news

Blogs on Neurofibromatosis type 1 causes

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Neurofibromatosis type 1 causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.

Overview

Neurofibromatosis type 1 can be caused 50% of the time due to an autosomal dominant inherited pattern with the other 50% beign caused due to a de novo mutation on NF1 gene. To review risk factors for the development of neurofibromatosis type 1, click here.

Causes

De novo mutation

Causes for NF1 gene mutation Percentage
Small deletions 22.4%[6]
Non-sense mutations 17.5%[6]
Deletion of several exons 15.5%[6]
Missense mutations 11.8%[6]
Small insertions 11%[6]
Intronic mutations affecting RNA splicing 10.2%[6]
Deletions of the entire NF1 gene 7.2%[6]
Chromosomal anomalies 1.6%[6]
3-UTR region mutations 1.6%[6]
Large insertions 1.2%[6]

Inherited (familial)



References

  1. 1.0 1.1 1.2
  2. McKeever K, Shepherd CW, Crawford H, Morrison PJ (September 2008). "An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age". Ulster Med J. 77 (3): 160–3. PMC 2604471. PMID 18956796.
  3. Bunin GR, Needle M, Riccardi VM (1997). "Paternal age and sporadic neurofibromatosis 1: a case-control study and consideration of the methodologic issues". Genet. Epidemiol. 14 (5): 507–16. doi:10.1002/(SICI)1098-2272(1997)14:5<507::AID-GEPI5>3.0.CO;2-Y. PMID 9358268.
  4. 4.0 4.1 4.2 Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Stephens K, Amemiya A, Friedman JM. PMID 20301288. Vancouver style error: initials (help); Missing or empty |title= (help)
  5. Upadhyaya M, Majounie E, Thompson P, Han S, Consoli C, Krawczak M, Cordeiro I, Cooper DN (January 2003). "Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1". Hum. Genet. 112 (1): 12–7. doi:10.1007/s00439-002-0840-1. PMID 12483293.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.7 6.8 6.9 "www.orpha.net" (PDF).
  7. "Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland | Journal of Medical Genetics".
  8. 8.0 8.1
  9. 9.0 9.1 "Neurofibromatosis type 1 - Genetics Home Reference - NIH".
  10. Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (February 2017). "Neurofibromatosis type 1". Nat Rev Dis Primers. 3: 17004. doi:10.1038/nrdp.2017.4. PMID 28230061.
  11. Huson SM, Compston DA, Clark P, Harper PS (November 1989). "A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity". J. Med. Genet. 26 (11): 704–11. doi:10.1136/jmg.26.11.704. PMC 1015740. PMID 2511318.
  12. Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A (June 2009). "Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome". Am. J. Med. Genet. A. 149A (6): 1263–7. doi:10.1002/ajmg.a.32837. PMID 19449407.

Template:WH Template:WS